NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.
November 7, 2026 — Research Highlights: Compared to standard treatment, using antihypertensive medications to lower systolic blood pressure (the top number in a reading) below 120 mm Hg in middle-aged adults with Type 2 diabetes did not significantly reduce the incidence of cardiovascular death, stroke, heart attack and other cardiovascular events. There is still a chance of a modest but clinically relevant benefit from more intensive blood pressure-lowering treatment, and high blood pressure management in people with Type 2 diabetes should remain individualized, researchers said.
November 7, 2026 — Research Highlights: In a study of almost 1,900 adults, ages 70 years and older who had other chronic health conditions but not cardiovascular disease, those who stopped taking cholesterol-lowering statins had similar rates of heart attack, stroke and death after two years when compared to peers who continued taking statins. There was an increase in the number of heart attacks and strokes among a small number of older adults who discontinued statins in an extended follow-up of up to four years, compared to peers who continued taking the medications.
November 7, 2026 — Research Highlights: Selecting which volunteer community first responders were alerted to the scene of a cardiac arrest was overall more successful when alerting responders who had shorter estimated arrival times than only sending out alerts to responders who were geographically closer to the scene and also reduced dispatching volunteers likely to get to the scene after EMS, according to preliminary research conducted by researchers in Freiburg, Germany. Because “smart” alerting considered obstacles related to how fast the responder could get to the scene, this method nearly doubled the chance of early volunteer arrival compared with alerts sent only to responders within the nearby geographical area.
November 7, 2026 — Research Highlights: Stroke and TIA survivors in Brazil who received medications to lower systolic blood pressure(the top number of a blood pressure reading) to less than 120 mm Hg were significantly less likely to die or have cardiovascular events within 4 years, compared to those who received standard treatment to lower levels below 140 mm Hg. During the four-year intervention of more than 4,000 people, more intensive blood pressure control reduced the risk of major cardiovascular events by about 21%, compared to standard treatment.
November 7, 2026 — Research Highlights: Adding the diuretic medication spironolactone to post-stroke care for adults with uncontrolled high blood pressure resulted in average systolic blood pressure (the top number) that was nearly 8 mm Hg lower at three months compared with usual post-stroke care. Spironolactone is a low-cost diuretic medication (or water pill) that helps the body excrete salt and water to prevent buildup, and it is usually added later in blood pressure treatment, typically when blood pressure stays high despite three other medications.
November 7, 2026 — Research Highlights: In the 7-year, phase III, multicenter, international Lp(a) HORIZON trial, the novel medication pelacarsen lowered Lp(a) levels by a mean of 78% in a trial with more than 8,300 adults with cardiovascular disease in 42 countries. However, even with a significant reduction in Lp(a) levels while taking pelacarsen, there was no change in the time to occurrence of a major adverse cardiovascular event (MACE), defined in this trial as nonfatal heart attack, stroke, an urgent revascularization procedure to open clogged heart arteries or death from any cardiovascular cause.
November 7, 2026 — Research Highlights: Inflammation is a target for cardiovascular risk reduction. However, there are currently limited options to reduce inflammation among people with chronic kidney disease.
November 6, 2026 — The new market analysis site turns technical analysis into a clear "market weather" view, with a pivot, two targets and an alternative scenario for every market, plus interactive charts and an open accuracy record BELIZE CITY, BELIZE - November 6, 2026 (NEWMEDIAWIRE) - Kumocast. io launched this week as a free market analysis website that publishes live trading signals, price predictions and forecasts for 50 of the most-followed markets in forex, commodities, stock indices and US equities.
November 6, 2026 — SAN CLEMENTE, CA - November 6, 2026 (NEWMEDIAWIRE) - The Marygold Companies, Inc. (the “Company” or “Marygold”) (NYSE American: MGLD), a global holding firm with a focus on financial services, today reported financial results for its first fiscal quarter ended September 30, 2026.
November 6, 2026 — CEO Dr. Sudhir Srivastava, in a recent interview with The Motley Fool, that SS Innovations has performed more than 15,000 procedures using its SSi Mantra robotic surgical systems, including approximately 750 cardiac procedures.
November 6, 2026 — DETROIT, MICHIGAN - November 6, 2026 (NEWMEDIAWIRE) - PCM Encore, a technology-forward, independent fiduciary wealth management firm, today announced that it is an official sponsor of the Benzinga Awards 2026, taking place on November 19, 2026. The awards recognize the financial companies, products and platforms that serve customers best across banking, credit cards, crypto, investing, lending, retirement, taxes and more.
November 6, 2026 — Extended, Deliberate Closing Process Prioritized a Cleaner Capital Structure - Restructuring and Converting out a Significant Portion of Legacy Convertible Debt Ahead of the Acquisition to Limit Dilution and Protect Long-term Shareholders MIAMI, FL - November 6, 2026 (NEWMEDIAWIRE) - Unique Global Innovative Solutions Corporation (OTC: UGIZ) (the “Company”) today announced the completion and finalization of its acquisition by AO Capital Partners, an affiliate of GBS Capital. The closing marks the culmination of an extended and deliberate negotiation process and clears the way for the Company’s planned entry into oil and gas service operations in Venezuela under an incoming management team led by Javier Sanguino García as Chief Executive Officer.
November 6, 2026 — - Global Wines and Spirits Presented in Hong Kong Featuring Eight Major Spirit Categories; Event Opens to Public on Saturday HONG KONG - November 6, 2026 (NEWMEDIAWIRE) - The 18th edition of the Hong Kong International Wine & Spirits Fair, organised by the Hong Kong Trade Development Council (HKTDC), opens today and runs for three days (5 to 7 November) at the Hong Kong Convention and Exhibition Centre. On the final day of the fair (7 November), the designated "Saturday Fiesta" zone will open to the public aged 18 or above, offering an opportunity to sample fine wines and spirits from around the world, join a series of themed activities and experience diverse drinking cultures.
November 5, 2026 — At EUR 55. 2 million in the first half of 2026/2027, Group revenues slightly below the previous year, as expected EBIT margin widens to 8.
November 5, 2026 — Group makes targeted investments in state-of-the-art medical technology Number of patients treated up 8. 3%, with revenues increasing toEUR 1,304 million Increase in the operating result is driven by a 3.
November 5, 2026 — Cash capital increase with subscription rights runs until 18 November 2026, over-subscription permitted The issue volume amounts to up to EUR 13,017,479. 00 Backstop commitment of up to EUR 12 million from a strategic investor Investor call on 11 October 2026, 11:00 a.
November 5, 2026 — A total of 82,265 patients treated in the first nine months of 2026 (previous year: 81,564) Group operating result rose to EUR 585. 9 million (previous year: EUR 563.
